Stephen P Mulligan (Stephen Mulligan)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 16

Top Topics

Replacement Therapy

Chronic Lymphocytic Leukemia

Diffuse Large B Cell Lymphoma

Top Venues

British journal of haematology

Leukemia & lymphoma

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas E Lew, Rory Bennett, Victor S Lin, Ashley Whitechurch, Sasanka Mithila Handunnetti, Paula Marlton, Yandong Shen, Stephen P Mulligan, Joshua Casan, Piers Blombery, Constantine S Tam, Andrew W Roberts, John Francis Seymour, Phillip A Thompson, Mary A Anderson
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon. Blood advances 8 (6) (2024)
Constantine S Tam, Stephen Opat, Shirley P D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G Owen, Paula Marlton, Björn E Wahlin, Miriam Santero, Helen McCarthy, Stephen P Mulligan, Alessandra Tedeschi, Jorge J Castillo, Jaroslaw Czyz, Carlos Fernández de Larrea, David Belada, Edward N Libby, Jeffrey V Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trněný, Monique C Minnema, Christian Buske, Véronique Leblond, Steven P Treon, Judith Trotman, Binghao Wu, Yiling Yu, Zhirong Shen, Wai Y Chan, Jingjing Schneider, Heather Allewelt, Aileen Cohen, Meletios-Athanasios A Dimopoulos
Biomarker analysis of the ASPEN study comparing zanubrutinib to ibrutinib in patients with Waldenström Macroglobulinemia. Blood advances (2024)
Constantine S Tam, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G Owen, Paula Marlton, Björn E Wahlin, Miriam Santero, Helen McCarthy, Stephen P Mulligan, Alessandra Tedeschi, Jorge J Castillo, Jarosław Czyż, Carlos Fernández de Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trněný, Monique C Minnema, Christian Buske, Véronique Leblond, Steven P Treon, Judith Trotman, Binghao Wu, Yiling Yu, Zhirong Shen, Wai Y Chan, Jingjing Schneider, Heather Allewelt, Aileen Cohen, Meletios A Dimopoulos
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia. Blood advances 8 (7) (2024)
Constantine S Tam, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G Owen, Paula Marlton, Björn E Wahlin, Miriam Santero, Helen McCarthy, Stephen P Mulligan, Alessandra Tedeschi, Jorge J Castillo, Jarosław Czyż, Carlos Fernández de Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trněný, Monique C Minnema, Christian Buske, Véronique Leblond, Steven P Treon, Judith Trotman, Binghao Wu, Yiling Yu, Zhirong Shen, Wai Y Chan, Jingjing Schneider, Heather Allewelt, Aileen Cohen, Meletios A Dimopoulos
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia. Blood advances 8 (7) (2024)
Constantine S Tam, Stephen Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G Owen, Paula Marlton, Björn E Wahlin, Miriam Santero, Helen McCarthy, Stephen P Mulligan, Alessandra Tedeschi, Jorge J Castillo, Jarosław Czyż, Carlos Fernández de Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trněný, Monique C Minnema, Christian Buske, Véronique Leblond, Steven P Treon, Judith Trotman, Binghao Wu, Yiling Yu, Zhirong Shen, Wai Y Chan, Jingjing Schneider, Heather Allewelt, Aileen Cohen, Meletios A Dimopoulos
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia. Blood advances 8 (7) (2024)
Thomas E Lew, Rory Bennett, Victor S Lin, Ashley Whitechurch, Sasanka Mithila Handunnetti, Paula Marlton, Yandong Shen, Stephen P Mulligan, Joshua Casan, Piers Blombery, Constantine S Tam, Andrew W Roberts, John Francis Seymour, Phillip A Thompson, Mary A Anderson
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon. Blood advances 8 (6) (2024)
Thomas E Lew, Rory Bennett, Victor S Lin, Ashley Whitechurch, Sasanka Mithila Handunnetti, Paula Marlton, Yandong Shen, Stephen P Mulligan, Joshua Misha Lewis Casan, Piers Blombery, Constantine S Tam, Andrew W Roberts, John Francis Seymour, Phillip A Thompson, Mary Ann Anderson
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon. Blood advances (2024)
Yandong Shen, Jane A Freeman, Ian Kerridge, Paul Downe, Kartik Naidu, Juliette Holland, Stephen P Mulligan
Repeated COVID-19 vaccination to maximum antibody response yields very low mortality and hospitalisation rates in patients with CLL and MBL. British journal of haematology (2023)
Meletios- Athanasios Dimopoulos, Stephen Samuel Opat, Shirley D'Sa, Wojciech Jurczak, Hui-Peng Lee, Gavin Cull, Roger G Owen, Paula Marlton, Björn Engelbrekt Wahlin, Miriam Santero, Helen McCarthy, Stephen P Mulligan, Alessandra Tedeschi, Jorge J Castillo, Jarosław Czyż, Carlos Fernández de Larrea, David Belada, Edward Libby, Jeffrey Matous, Marina Motta, Tanya Siddiqi, Monica Tani, Marek Trněný, Monique C Minnema, Christian Buske, Veronique Leblond, Steven P Treon, Judith Trotman, Wai Y Chan, Jingjing Schneider, Heather Allewelt, Sheel Patel, Aileen Cohen, Constantine S Tam
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Stephen P Mulligan
Karyotype and outcome in CLL. Blood 142 (5) (2023)
Ross Thomas Salvaris, Stephen P Mulligan, Andrea Puig, Marija McGeachie, Stephen Samuel Opat
Australian data on the utilisation and duration on treatment of ibrutinib with a proton pump inhibitor in patients with relapsed or refractory chronic lymphocytic leukaemia. Internal medicine journal (2023)
Anastazia Keegan, Peta M Dennington, Nina Dhondy, Stephen P Mulligan
Immunoglobulin replacement therapy in chronic lymphocytic leukaemia patients with hypogammaglobulinaemia and infection. European journal of haematology 108 (6) (2022)
Yandong Shen, Jane A Freeman, Juliette Holland, Ann Solterbeck, Kartik Naidu, Asha Soosapilla, Paul Downe, Catherine Tang, Ian Kerridge, Lucinda Wallman, Nenna Van Bilsen, Vanessa Milogiannakis, Anouschka Akerman, Gabriela Martins Costa Gomes, Kerrie Sandgren, Anthony L Cunningham, Stuart Turville, Stephen P Mulligan
COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity. British journal of haematology 197 (1) (2022)
Catherine Tang, Yandong Shen, Asha Soosapilla, Stephen P Mulligan
Monoclonal B-cell Lymphocytosis - a review of diagnostic criteria, biology, natural history, and clinical management. Leukemia & lymphoma 63 (12) (2022)
Stephen P Mulligan, Stephen Samuel Opat, Chan Yoon Y Cheah, Bryone Kuss, Mark Hertzberg, Paula Marlton, Sarah Poplar, Andrea Puig, Marija McGeachie, Robert Weinkove, Constantine S Tam
Real-world experience of Australian and New Zealand patients with chronic lymphocytic leukemia and mantle cell lymphoma accessing ibrutinib through a Named Patient Program. Leukemia & lymphoma (2022)
Stephen P Mulligan, Stephen Samuel Opat, Paula Marlton, Bryone J Kuss, Poppy Gerungan, Andrea Puig, Marija McGeachie, Constantine S Tam
Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia. British journal of haematology 198 (4) (2022)